查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475203

全球生物安全检测产品和服务市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Biological Safety Testing Products And Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 236 Pages | 商品交期: 最快1-2个工作天内

价格

全球生物安全检测产品和服务市场的需求预计将从2023年的50.1亿美元达到2032年的近128.8亿美元，2024-2032年研究期间的复合年增长率为11.06%。

生物安全检测产品和服务包括一系列用于评估疫苗、单株抗体、细胞疗法、基因疗法和重组蛋白等生物製药产品的安全性、纯度和效力的测定、试剂、消耗品、设备和实验室服务。这些产品和服务对于确保遵守监管机构（包括美国食品和药物管理局 (FDA) 和欧洲药品管理局 (EMA)）制定的监管要求和品质标准至关重要。生物安全测试涉及透过细胞测定、分子测定、免疫测定、微生物测定和生物测定来评估生物製品中是否存在污染物、毒素、外来物质和杂质。

市场动态

对生物药物、疫苗和生物製剂不断增长的需求推动了对原料、中间产品和最终製剂进行严格测试的需要，以确保其临床使用的安全性、纯度和有效性。随着生物製药研发的兴起、新型生物製剂和生物相似药的开发以及药品供应链的日益全球化等因素，人们越来越重视综合测试方案、风险缓解策略和品质控制措施，以应对新出现的生物危害、污染风险和监管要求。此外，分析技术、基于细胞的测定和分子生物学方法的进步使得创新的生物安全检测产品和服务的开发成为可能，这些产品和服务可以对生物製药产品和製造中的微生物污染物、外来物质和杂质进行灵敏、特异且可靠的检测流程。

此外，越来越多地采用体外和体内测试方法，例如细胞培养测定、核酸扩增技术和动物模型，推动了生物安全测试产品和服务市场的创新，因为公司寻求成本效益、高通量和预测测试平台可简化产品开发、加速监管核准并确保病患安全。此外，生物製药产品、製造流程和监管要求日益复杂，推动了市场对专业测试服务、咨询和外包解决方案的需求。然而，监管要求、技术进步和安全标准日益复杂可能会挑战未来几年生物安全检测产品和服务市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球生物安全检测产品和服务市场的各个细分市场进行包容性评估。生物安全检测产品和服务业的成长和趋势为本研究提供了整体方法。

市场区隔

生物安全检测产品和服务市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 试剂和试剂盒
  • 服务
  • 仪器

按申请

  • 疫苗及治疗药物（疫苗、单株抗体、重组蛋白）
  • 血液和血液製品
  • 基因治疗
  • 组织和组织基产品
  • 干细胞

按测试类型

  • 内毒素测试
  • 无菌测试
  • 细胞株验证和表征测试
  • 生物负载测试
  • 外来因子检测测试
  • 残留宿主污染检测测试
  • 其他的

区域分析

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲生物安全检测产品和服务市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。生物安全检测产品和服务市场的主要参与者包括 Charles River Laboratories、BSL Bioservice、Merck KGaA (MilliporeSigma)、Samsung Biologics、Sartorius AG、Eurofins Scientific、SGS Societe Generale de Surveillance SA、Thermo Fisher Scientific Inc.、Biomerieux、龙沙。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：生物安全检测产品与服务 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按测试类型进行的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球生物安全检测产品与服务市场分析：按产品

  • 概述（按产品）
  • 历史和预测数据
  • 按产品分析
  • 试剂和试剂盒
  • 服务
  • 仪器

第 6 章：全球生物安全检测产品与服务市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 疫苗及治疗药物（疫苗、单株抗体、重组蛋白）
  • 血液和血液製品
  • 基因治疗
  • 组织和组织基产品
  • 干细胞

第 7 章：全球生物安全测试产品与服务市场分析：依测试类型

  • 按测试类型概述
  • 历史和预测数据
  • 按测试类型分析
  • 内毒素测试
  • 无菌测试
  • 细胞株验证和表征测试
  • 生物负载测试
  • 外来因子检测测试
  • 残留宿主污染检测测试
  • 其他的

第 8 章：全球生物安全检测产品与服务市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章：生物安全侦测产品与服务公司的竞争格局

  • 生物安全检测产品与服务市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Charles River Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BSL Bioservice
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck KGaA (MilliporeSigma)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Samsung Biologics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sartorius AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Eurofins Scientific
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • SGS SocieTe GeNeRale De Surveillance SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BiomeRieux
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Lonza
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR112114348

The global demand for Biological Safety Testing Products And Services Market is presumed to reach the market size of nearly USD 12.88 Billion by 2032 from USD 5.01 Billion in 2023 with a CAGR of 11.06% under the study period 2024 - 2032.

Biological safety testing products and services encompass a range of assays, reagents, consumables, equipment, and laboratory services used for assessing the safety, purity, and potency of biopharmaceutical products such as vaccines, monoclonal antibodies, cell therapies, gene therapies, and recombinant proteins. These products & services are crucial for ensuring compliance with regulatory requirements and quality standards set forth by regulatory agencies, including the U.S. Food and Drug Administration (FDA) & the European Medicines Agency (EMA). Biological safety testing involves evaluating the presence of contaminants, toxins, adventitious agents, and impurities in biological products through cell-based assays, molecular assays, immunoassays, microbiological assays, and bioassays.

MARKET DYNAMICS

The growing demand for biological drugs, vaccines, and biologics drives the need for rigorous testing of raw materials, intermediate products, and final formulations to ensure their safety, purity, and efficacy for clinical use. With factors such as the rise in biopharmaceutical R&D, the development of novel biologics and biosimilars, and the increasing globalization of pharmaceutical supply chains, there is a growing emphasis on comprehensive testing protocols, risk mitigation strategies, and quality control measures to address emerging biological hazards, contamination risks, and regulatory requirements. Additionally, advancements in analytical techniques, cell-based assays, and molecular biology methods enable the development of innovative biological safety testing products and services that offer sensitive, specific, and reliable detection of microbial contaminants, adventitious agents, and impurities in biopharmaceutical products and manufacturing processes.

Moreover, the increasing adoption of in vitro and in vivo testing methods, such as cell culture assays, nucleic acid amplification techniques, and animal models, drives biological safety testing products and services market innovation as companies seek cost-effective, high-throughput, and predictive testing platforms that streamline product development, accelerate regulatory approval, and ensure patient safety. Furthermore, the growing complexity of biopharmaceutical products, manufacturing processes, and regulatory requirements drives market demand for specialized testing services, consultancy, and outsourcing solutions. However, the increasing complexity of regulatory requirements, technological advancements, and safety standards may challenge the growth of the biological safety testing products and services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biological safety testing products and services. The growth and trends of biological safety testing products and services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the biological safety testing products and services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Reagents & Kits
  • Services
  • Instruments

By Application

  • Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein)
  • Blood & Blood-Based Products
  • Gene Therapy
  • Tissue & Tissue-Based Products
  • Stem Cell

By Test Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication & Characterization Tests
  • Bioburden Tests
  • Adventitious Agent Detection Tests
  • Residual Host Contamination Detection Tests
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biological Safety Testing Products And Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biological Safety Testing Products And Services market include Charles River Laboratories, BSL Bioservice, Merck KGaA (MilliporeSigma), Samsung Biologics, Sartorius AG, Eurofins Scientific, SGS Societe Generale de Surveillance SA, Thermo Fisher Scientific Inc., Biomerieux, Lonza. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Test Type
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Reagents & Kits Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions
  • 5.6. Instruments Historic and Forecast Sales By Regions

6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Application
  • 6.4. Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Historic and Forecast Sales By Regions
  • 6.5. Blood & Blood-based Products Historic and Forecast Sales By Regions
  • 6.6. Gene Therapy Historic and Forecast Sales By Regions
  • 6.7. Tissue & Tissue-based Products Historic and Forecast Sales By Regions
  • 6.8. Stem Cell Historic and Forecast Sales By Regions

7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY TEST TYPE

  • 7.1. Overview By Test Type
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Test Type
  • 7.4. Endotoxin Tests Historic and Forecast Sales By Regions
  • 7.5. Sterility Tests Historic and Forecast Sales By Regions
  • 7.6. Cell Line Authentication & Characterization Tests Historic and Forecast Sales By Regions
  • 7.7. Bioburden Tests Historic and Forecast Sales By Regions
  • 7.8. Adventitious Agent Detection Tests Historic and Forecast Sales By Regions
  • 7.9. Residual Host Contamination Detection Tests Historic and Forecast Sales By Regions
  • 7.10. Others Historic and Forecast Sales By Regions

8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES COMPANIES

  • 9.1. Biological Safety Testing Products And Services Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF BIOLOGICAL SAFETY TESTING PRODUCTS AND SERVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Charles River Laboratories
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. BSL Bioservice
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck KGaA (MilliporeSigma)
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Samsung Biologics
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Sartorius AG
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Eurofins Scientific
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. SGS SocieTe GeNeRale De Surveillance SA
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. BiomeRieux
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Lonza
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Market Sales By Geography (USD MN)
  • Blood & Blood-based Products Market Sales By Geography (USD MN)
  • Gene Therapy Market Sales By Geography (USD MN)
  • Tissue & Tissue-based Products Market Sales By Geography (USD MN)
  • Stem Cell Market Sales By Geography (USD MN)
  • Analysis By Test Type (USD MN)
  • Endotoxin Tests Market Sales By Geography (USD MN)
  • Sterility Tests Market Sales By Geography (USD MN)
  • Cell Line Authentication & Characterization Tests Market Sales By Geography (USD MN)
  • Bioburden Tests Market Sales By Geography (USD MN)
  • Adventitious Agent Detection Tests Market Sales By Geography (USD MN)
  • Residual Host Contamination Detection Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Biological Safety Testing Products And Services Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biological Safety Testing Products And Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Biological Safety Testing Products And Services Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Test Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Reagents & Kits Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Vaccines & Therapeutics (Vaccines, Monoclonal Antibodies, Recombinant Protein) Market Sales By Geography (USD MN)
  • Blood & Blood-based Products Market Sales By Geography (USD MN)
  • Gene Therapy Market Sales By Geography (USD MN)
  • Tissue & Tissue-based Products Market Sales By Geography (USD MN)
  • Stem Cell Market Sales By Geography (USD MN)
  • Global Market Analysis By Test Type (USD MN)
  • Endotoxin Tests Market Sales By Geography (USD MN)
  • Sterility Tests Market Sales By Geography (USD MN)
  • Cell Line Authentication & Characterization Tests Market Sales By Geography (USD MN)
  • Bioburden Tests Market Sales By Geography (USD MN)
  • Adventitious Agent Detection Tests Market Sales By Geography (USD MN)
  • Residual Host Contamination Detection Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.